1-3 of 3
Sathyen A Prabhu
Close
Sort by
Journal Articles

High Expression of FGF2/SDC1 Signaling Contributes to Poor Clinical Outcome in Hodgkin Lymphoma Patients and SDC1 siRNA Suppresses Proliferation, Migration, and Invasion in Hodgkin Lymphoma Cells

Poonam Nagpal, PhD, Andre Goy, MD, Anju Gangadharan, PhD, Mohamed R. Akl, PhD, Ivan Voznenko, BA, Mihir Soni, BS, Betty Tai, BA, Tasheka Cousins, BA, Tatyana A Feldman, MD, Sathyen A. Prabhu, MS, Amanda Ally, BS, Morgan Anderson-Crannage, BS, Lori A. Leslie, MD, Lady K., MD, Fareeha Kanwal, MS, Tatsunari Tomiyama, BS, Aliya Khurram, MD, Catherine M. Capac, MS, Matthew Gliksman, BS, Despina Helios, Dante B. Descalzi-Montoya, PhD, Andrew L. Pecora, MD, K. Stephen Suh, PhD
Journal: Blood
Blood (2017) 130 (Supplement 1): 1483.
https://doi.org/10.1182/blood.V130.Suppl_1.1483.1483
Published: 2017
Journal Articles

Epigenetic Targeting with EZH2 and HDAC Inhibitors Is Synergistic in EZH2 Deregulated Lymphomas

Jennifer Kimberly Lue, MD, Sathyen A Prabhu, Yuxuan Liu, PhD, Owen A. O'Connor, MD PhD, Jennifer E Amengual, MD
Journal: Blood
Blood (2016) 128 (22): 839.
https://doi.org/10.1182/blood.V128.22.839.839
Published: 2016
Journal Articles

Mechanisms of Acquired Drug Resistance to the Isoform Selective HDAC6 Inhibitor Ricolinostat Reveals Markedly Upregulated Elements of the BTK Pathway Revealing Rational Drug : Drug Combinations

Jennifer E Amengual, MD, Maximilian Lombardo, Kelly M Zullo, Paul M. Johannet, BA, Sathyen A Prabhu, Gonzalez Yulissa, Luigi Scotto, PhD, Ying Wei, Jimmy Duong, Owen A. O'Connor, MD PhD
Journal: Blood
Blood (2015) 126 (23): 3708.
https://doi.org/10.1182/blood.V126.23.3708.3708
Published: 2015